[Current topics of treatment for glioma and mechanism of drug resistance].
Nagane
Motoo
M
Department of Neurosurgery, Kyorin University School of Medicine, Tokyo, Japan.
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D002872:Chromosome Deletion; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005910:Glioma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D006801:Humans; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000378:metabolism; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide